Literature DB >> 12819253

Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis.

Wilhelm Kriz1, Bruni Hähnel, Hiltraud Hosser, Tammo Ostendorf, Soeren Gaertner, Bettina Kränzlin, Norbert Gretz, Fujio Shimizu, Jürgen Floege.   

Abstract

The present histopathologic study of anti-Thy-1.1 models of mesangioproliferative glomerulonephritis in rats provides a structural analysis of damage development and of pathways to recovery and to nephron loss. As long as the disease remains confined to the endocapillary compartment, the damage may be resolved or recover with a mesangial scar. Irreversible lesions with loss of nephrons emerge from extracapillary processes with crucial involvement of podocytes, leading to tuft adhesions to Bowman's capsule (BC) and subsequent crescent formation. Two mechanisms appeared to be responsible: (1) Epithelial cell proliferation at BC and the urinary orifice and (2) misdirected filtration and filtrate spreading on the outer aspect of the nephron. Both may lead to obstruction of the tubule, disconnection from the glomerulus, and subsequent degeneration of the entire nephron. No evidence emerged to suggest that the kind of focal interstitial proliferation associated with the degeneration of injured nephrons was harmful to a neighboring healthy nephron.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819253     DOI: 10.1097/01.asn.0000070073.79690.57

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  25 in total

Review 1.  Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells.

Authors:  Yohei Maeshima
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

Review 2.  Autonomous innervation in renal inflammatory disease-innocent bystander or active modulator?

Authors:  Tilmann Ditting; Gisa Tiegs; Roland Veelken
Journal:  J Mol Med (Berl)       Date:  2009-07-12       Impact factor: 4.599

Review 3.  Mechanical challenges to the glomerular filtration barrier: adaptations and pathway to sclerosis.

Authors:  Wilhelm Kriz; Kevin V Lemley
Journal:  Pediatr Nephrol       Date:  2016-03-23       Impact factor: 3.714

Review 4.  Problems with 'focal segmental glomerulosclerosis'.

Authors:  Alexander J Howie
Journal:  Pediatr Nephrol       Date:  2010-12-02       Impact factor: 3.714

5.  Afferent arteriolopathy and glomerular collapse but not segmental sclerosis induce tubular atrophy in old spontaneously hypertensive rats.

Authors:  Sabine Leh; Michael Hultström; Christian Rosenberger; Bjarne M Iversen
Journal:  Virchows Arch       Date:  2011-06-10       Impact factor: 4.064

6.  Alteration of podocytes in a murine model of crescentic glomerulonephritis.

Authors:  Valérie Besse-Eschmann; Michel Le Hir; Nicole Endlich; Karlhans Endlich
Journal:  Histochem Cell Biol       Date:  2004-08       Impact factor: 4.304

7.  Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease.

Authors:  Samy Hakroush; Marcus J Moeller; Franziska Theilig; Brigitte Kaissling; Tjeerd P Sijmonsma; Manfred Jugold; Ann L Akeson; Milena Traykova-Brauch; Hiltraud Hosser; Brunhilde Hähnel; Hermann-Josef Gröne; Robert Koesters; Wilhelm Kriz
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

Review 8.  Serine proteases, inhibitors and receptors in renal fibrosis.

Authors:  Allison A Eddy
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

Review 9.  [IgA nephropathy: frequent, but rarely diagnosed].

Authors:  J Floege; H-J Gröne
Journal:  Internist (Berl)       Date:  2003-09       Impact factor: 0.743

10.  Recruitment of podocytes from glomerular parietal epithelial cells.

Authors:  Daniel Appel; David B Kershaw; Bart Smeets; Gang Yuan; Astrid Fuss; Björn Frye; Marlies Elger; Wilhelm Kriz; Jürgen Floege; Marcus J Moeller
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.